Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -13.88x is 99% below its 5-year average of -6.98x, around the middle of its 5-year range (-37.06x–2.60x).
As of the fiscal period ended Monday, December 31, 2018. 86.06% below its 12-month average of -7.46x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2018 (2018-12-31): -13.88x.
INTEREST COVERAGE RATIO
-13.88x
INTEREST COVERAGE RATIO AVG TTM
-7.46x
INTEREST COVERAGE RATIO AVG 3Y
-9.81x
INTEREST COVERAGE RATIO AVG 5Y
-6.98x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-86.06%
CURRENT VS 3Y AVG
-41.54%
CURRENT VS 5Y AVG
-98.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.95x
median of 420 covered companies
CURRENT VS SECTOR MEDIAN
-180.39%
vs the sector median at left
CareDx, Inc
Market Cap
$3.41B
Interest Coverage Ratio
-13.88x
TTM Avg
-7.46x
3Y Avg
-9.81x
5Y Avg
-6.98x
Market Cap
$3.44B
Interest Coverage Ratio
N/A
TTM Avg
407.95x
3Y Avg
407.95x
5Y Avg
407.95x
Market Cap
$3.40B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.52B
Interest Coverage Ratio
-2.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.39B
Interest Coverage Ratio
-99.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.56B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.12B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.09B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CareDx, Inc (CDNA) | $3.41B | -13.88x | -7.46x | -9.81x | -6.98x |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | N/A | 407.95x | 407.95x | 407.95x |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.40B | N/A | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | -2.80x | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.39B | -99.92x | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.56B | N/A | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.55B | -10.04x | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.12B | N/A | N/A | N/A | N/A |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.09B | N/A | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.10B | N/A | N/A | N/A | N/A |
Interest Coverage
-13.9x
Debt/Equity
0.05
Current Ratio
4.58
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2018-12-31 | -13.88x |
| 2018-09-30 | -6.66x |
| 2018-06-30 | -12.29x |
| 2018-03-31 | -1.94x |
| 2017-12-31 | -2.53x |
| 2017-09-30 | -2.29x |
| 2017-06-30 | -2.13x |
| 2017-03-31 | -10.82x |
| 2016-12-31 | -37.06x |
| 2016-09-30 | -8.68x |
| 2016-06-30 | -14.12x |
| 2016-03-31 | -24.70x |
| 2015-12-31 | -17.64x |
| 2015-09-30 | -12.72x |
| 2015-06-30 | -11.27x |
| 2015-03-31 | -1.68x |
| 2014-12-31 | 1.10x |
| 2014-09-30 | 2.60x |
| 2014-06-30 | -0.54x |
| 2014-03-31 | -0.41x |
| 2013-12-31 | 0.93x |
| 2013-09-30 | -0.67x |
| 2013-06-30 | -0.47x |
| 2013-03-31 | -1.38x |
